Literature DB >> 6973480

Lyt phenotypes of primary cytotoxic T cells generated across the A and E region of the H-2 complex.

D Vidovic, A Juretic, Z A Nagy, J Klein.   

Abstract

Six different cell-mediated lympholysis (CML) combinations were established, four of which generated effector cells against the I-E, and two against the I-A molecule. The cell surface phenotype of effector cells was then determined by depletion of cytotoxic T lymphocyte (CTL) activity with antisera and rabbit complement (C) treatment. Both types of effector cells were completely eliminated by treatment with anti-Thy-1.2 antiserum plus C. Anti-Lyt-1.2 and C depleted anti-A and anti-E killer activity but did not eliminate CTL generated across a whole H-2 difference. One out of three different batches of anti-Lyt-2.2 antiserum did not deplete anti-A killer activity, while it efficiently eliminated CTL generated across the E region or whole H-2 difference. However, two batches of anti-Lyt-2.2 antiserum depleted also anti-A CTL activity. A quantitative difference between anti-A and anti-E CTL in terms of Lyt-2 expression was demonstrated by significant differences in recovery of killer activity, after treatment of these two types of CTL with a wide concentration range of the same anti-Lyt-2.2 antiserum and C. Thus it is concluded that anti-A killer cells have the cell surface phenotype of Thy-1+, Lyt-1, Lyt-2, whereas anti-E CTL are Thy-1+, Lyt-1, Lyt-2. The data are discussed in the context of a possible association of Lyt phenotypes of T cells with the type of MHC antigens they recognize.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6973480     DOI: 10.1002/eji.1830110611

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  15 in total

1.  Immunofluorescent flow cytometry in N dimensions. The multiplex labeling approach.

Authors:  T N Buican; G W Hoffmann
Journal:  Cell Biophys       Date:  1985-06

Review 2.  Antigen-major histocompatibility complex-T cell receptors: inquiries into the immunological ménage à trois.

Authors:  J Klein
Journal:  Immunol Res       Date:  1986       Impact factor: 2.829

Review 3.  Virus-immune T cells and the major histocompatibility complex: evolution of some basic concepts over the past two years.

Authors:  P C Doherty
Journal:  Experientia       Date:  1986-09-15

4.  Flip-flop in the Lyt 2 phenotype of T cells from radiation chimaeras between Thy 1 congenic donor and recipient mice.

Authors:  D B Thomas; K D Keeler
Journal:  Immunology       Date:  1984-03       Impact factor: 7.397

5.  Antigen-specific helper T cells recognize determinants encoded in the H-2D region of the H-2 gene complex.

Authors:  L M Pilarski; T G Wegmann
Journal:  Immunogenetics       Date:  1984       Impact factor: 2.846

6.  Immunoregulation of genetically controlled acquired responses to Leishmania donovani infection in mice: demonstration and characterization of suppressor T cells in noncure mice.

Authors:  J M Blackwell; O M Ulczak
Journal:  Infect Immun       Date:  1984-04       Impact factor: 3.441

7.  Feedback control of the secondary antibody response. I. A suppressor, suppressor-inducer mechanism from the interaction of B-memory cells with Lyt 2- T cells.

Authors:  D B Thomas; M W Kennedy
Journal:  Immunology       Date:  1983-10       Impact factor: 7.397

8.  Cell-mediated cytotoxicity against HLA-D-region products expressed in monocytes and B lymphocytes. IV. Characterization of effector cells using monoclonal antibodies against human T-cell subsets.

Authors:  E J Ball; P Stastny
Journal:  Immunogenetics       Date:  1982       Impact factor: 2.846

9.  Alloreactive T-cell clones. Ly phenotypes predict both function and specificity for major histocompatibility complex products.

Authors:  A Rao; W J Allard; P G Hogan; R S Rosenson; H Cantor
Journal:  Immunogenetics       Date:  1983       Impact factor: 2.846

10.  Cytotoxic monoclonal antibody specific for the Lyt-1.2 antigen.

Authors:  C Mark; F Figueroa; Z A Nagy; J Klein
Journal:  Immunogenetics       Date:  1982       Impact factor: 2.846

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.